Daijiworld Media Network – New Delhi
New Delhi, Jul 23: Human three-dimensional (3D) organoid models are providing fresh insights into the biological mechanisms underlying motor neuron diseases, offering researchers new tools to study the progressive neurological disorders and identify potential therapeutic targets, according to a new review.
The study highlights how induced pluripotent stem cell (iPSC)-derived 3D organoid models can help unravel both cell-autonomous and non-cell-autonomous processes responsible for the degeneration of motor neurons, which eventually leads to paralysis and death.
Researchers noted that motor neuron diseases were once considered primarily disorders affecting nerve cells alone. However, growing evidence indicates that disease progression is influenced by complex interactions between motor neurons and surrounding cells, including glial cells and muscle tissue.
The review states that conventional research models have been unable to fully replicate these complex interactions, prompting the development of physiologically relevant 3D organoid systems.
The researchers examined several types of iPSC-derived models designed to mimic different aspects of motor neuron disease.
Spinal cord organoids were used to investigate disease mechanisms within motor neurons and their interactions with glial cells, while axially elongated spinal cord organoids helped researchers study developmental factors that may increase susceptibility to the disease.
Three-dimensional muscle organoids and combined neuromuscular models enabled scientists to examine muscle degeneration and the breakdown of neuromuscular junctions, which are critical communication points between nerves and muscles.
The review also highlighted advances in bioengineering, machine learning and human trunk-like models that allow researchers to simulate the coordinated development of multiple tissues affected by motor neuron diseases.
According to the authors, these integrated systems have significantly improved understanding of disease progression and may help identify existing drugs that could be repurposed to treat motor neuron disorders.
Spinal cord organoids have revealed important interactions between motor neurons and glial cells that contribute to disease progression, while neuromuscular models have successfully reproduced the deterioration of neuromuscular junctions associated with motor neuron loss.
The researchers emphasised that the publication is a review of existing evidence rather than a primary experimental study and therefore does not present new patient data, sample sizes or statistical analyses.
The review proposes a framework to help scientists select the most appropriate 3D models based on specific disease mechanisms and clinical characteristics, with the aim of accelerating future research and the development of effective therapies for motor neuron diseases.